Heron Therapeutics | Ativo Circulante





Ativo Circulante Alterar Data
ALKERMES USD 1.74B 106.38M 2025-09
Alnylam Pharmaceuticals USD 3.95B 309.11M 2025-09
Amarin USD 628.33M 21.52M 2025-09
ANI Pharmaceuticals USD 698.4M 95.77M 2025-09
Anika Therapeutics USD 101.59M 2.27M 2025-09
Arrowhead Research USD 1.17B 223.75M 2025-12
Eisai JPY 840.88B 50.18B 2025-12
Esperion Therapeutics USD 360.46M 17.87M 2025-09
GlaxoSmithKline GBP 17.51B 332M 2025-12
Heron Therapeutics USD 229.4M 18.48M 2025-09
Insmed USD 1.93B 149.77M 2025-09
Ligand Pharmaceuticals USD 753.92M 400.98M 2025-09
Merck USD 47.56B 10.49B 2025-09
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Neurocrine Biosciences USD 2.16B 409.5M 2025-09
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 562.75M 182.86M 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Surmodics USD 81.3M 948K 2024-09
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Veracyte USD 449.22M 34.54M 2025-09
Vertex Pharmaceuticals USD 10.57B 141.7M 2025-09


Heron Therapeutics Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.